Novartis AG (NYSE:NVS)

86.68
Delayed Data
As of Jun 01
 -0.75 / -0.86%
Today’s Change
69.18
Today|||52-Week Range
99.84
-8.46%
Year-to-Date
Novartis to Manufacture Mass General's Coronavirus Vaccine Candidate
May 28 / MotleyFool.com - Paid Partner Content
Here's Why Editas Could Beat Intellia to a CRISPR Therapy
May 22 / MotleyFool.com - Paid Partner Content
Is Coherus BioSciences a Buy?
May 26 / MotleyFool.com - Paid Partner Content
Is Alnylam Pharmaceuticals a Buy?
May 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close87.43
Today’s open87.57
Day’s range86.10 - 87.57
Volume1,089,866
Average volume (3 months)2,636,015
Market cap$200.2B
Data as of 3:59pm ET, 06/01/2020

Growth & Valuation

Earnings growth (last year)-43.54%
Earnings growth (this year)+5.68%
Earnings growth (next 5 years)+8.34%
Revenue growth (last year)-8.60%
P/E ratio26.8
Price/Sales4.62
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
MRKMerck-1.16-1.44%
PFEPfizer-2.73-7.15%
ABBVAbbVie-1.97-2.13%
LLYEli Lilly and Co-0.46-0.30%
Data as of 4:40pm ET, 06/01/2020

Financials

Next reporting dateJuly 21, 2020
EPS forecast (this quarter)$1.37
Annual revenue (last year)$47.5B
Annual profit (last year)$7.0B
Net profit margin15.04%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Basel, Basel-stadt (basle Town)

Forecasts